Interventional Radiology Market Report 2026

Interventional Radiology Market Overview

• Interventional Radiology market size has reached to $29.98 billion in 2025 • Expected to grow to $54.31 billion in 2030 at a compound annual growth rate (CAGR) of 12.5% • Growth Driver: Rising Cancer Prevalence Spurs Growth In The Interventional Radiology Market • Market Trend: Innovative AI-Enhanced Radiology Solutions Transforming The Interventional Radiology Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Interventional Radiology Market?

Interventional radiology is a field of radiology that uses medical imaging to guide minimally invasive surgical procedures for diagnosis and treatment. It is used to treat a wide range of conditions, including vascular blockages and tumors, while minimizing patient discomfort and recovery time. The main types of products in the interventional radiology market are MRI, ultrasound imaging, CT scanners, angiography systems, fluoroscopy systems, biopsy devices, and others. MRI interventional radiology devices scan produce detailed images of the organs and tissues in the body. The different procedures include angioplasty, angiography, biopsy and drainage, embolization, thrombolysis, vertebroplasty, nephrostomy, and others and are used in cardiology, urology and nephrology, oncology, gastroenterology, and others.

What Is The Interventional Radiology Market Growth Forecast?

The interventional radiology market size is expected to see rapid growth in the next few years. It will grow to $54.31 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing demand for precision oncology interventions, rising investments in advanced imaging systems, expansion of interventional radiology training programs, growing use of image-guided therapies, increasing preference for outpatient interventional procedures. Major trends in the forecast period include increasing adoption of image-guided minimally invasive procedures, rising integration of advanced imaging modalities, growing demand for precision-based interventional therapies, expansion of hybrid operating room installations, enhanced focus on procedure accuracy and patient outcomes.

Global Interventional Radiology Market Segmentation

1) By Product: Ultrasound Imaging, Angiography Systems, Fluoroscopy Systems, Biopsy Devices 2) By Procedure: Angioplasty, Angiography, Biopsy And Drainage, Embolization, Thrombolysis, Vertebroplasty, Nephrostomy 3) By Application: Oncology, Urology And Nephrology, Gastroenterology Subsegments: 1) By Ultrasound Imaging: Portable Ultrasound Systems, Diagnostic Ultrasound Systems, 3D/4D Ultrasound Systems 2) By Angiography Systems: Digital Subtraction Angiography (DSA) Systems, Mobile Angiography Systems, Hybrid Angiography Systems 3) By Fluoroscopy Systems: Fixed Fluoroscopy Systems, Mobile Fluoroscopy Systems, C-arm Fluoroscopy Systems 4) By Biopsy Devices: Needle Biopsy Devices, Vacuum-Assisted Biopsy Devices, Stereotactic Biopsy Devices

What Is The Driver Of The Interventional Radiology Market?

The increase in prevalence of cancer is expected to drive the growth of the interventional radiology market in the coming years. Cancer is a global health problem and is the second leading cause of death in the United States. Interventional radiology uses a variety of techniques, such as ablation, embolization, and irreversible electroporation (IRE), to treat cancer and cardiovascular disorders. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in Australia the number of cancer cases diagnosed increased from 160,570 in 2022 to 164,694 in 2023, reflecting a notable rise over the year. Therefore, the increasing prevalence of cancer drives the growth of the interventional radiology industry.

Key Players In The Global Interventional Radiology Market

Major companies operating in the interventional radiology market are Carestream Health Inc., Siemens Aktiengesellschaft, Koninklijke Philips N.V., General Electric Company, Hitachi Ltd., Canon Medical Systems Corporation, Shimadzu Corporation, FUJIFILM Holdings Corporation, Hologic Inc., Agfa-Gevaert N.V., Esaote S.p.A., Samsung Medison Co. Ltd., Cook Group Incorporated, Medtronic plc, Abbott Laboratories, AngioDynamics Inc., B. Braun Melsungen AG, C. R. Bard Inc., Terumo Corporation, Merit Medical Systems Inc., Penumbra Inc., BTG International Ltd., Guerbet Group, Medrad Inc., MicroPort Scientific Corporation, Neusoft Medical Systems Co. Ltd.

Global Interventional Radiology Market Trends and Insights

Major companies operating in the interventional radiology market are innovating new technological products such as the AI-powered Viz Radiology Suite to increase their profitability in the market. AI-powered Viz Radiology Suite refers to an advanced radiology workflow platform developed by Viz.ai that uses artificial intelligence to analyze medical images and support clinical decision-making. For instance, in October 2023, GE HealthCare, a U.S.-based medical technology company, received FDA 510(k) clearance for its Allia IGS Pulse system. This next-generation image-guided interventional platform includes an AI-enhanced “AutoRight PLUS” image chain that automatically optimizes seven imaging parameters in real time. The technology improves image quality, enhances visualization, and helps control radiation dose during interventional radiology procedures, enabling faster and more efficient clinical decision-making.

What Are Latest Mergers And Acquisitions In The Interventional Radiology Market?

In January 2023, GE HealthCare Technologies Inc., a US-based medical technology company, acquired IMACTIS for an undisclosed amount. The acquisition of IMACTIS was motivated by the chance to grow its interventional radiology business, incorporate complementary technologies, and improve its image-guided therapeutic solutions for clients and patients. MACTIS is a France-based medical technology company.

Regional Outlook

North America was the largest region in the interventional radiology global market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Interventional Radiology Market?

The interventional radiology market consists of sales of atherectomy systems, cancer therapies, and balloon catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.